These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 23683788

  • 1. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
    Narquin S, Ingrand P, Azais I, Delwail V, Vialle R, Boucebci S, Tasu JP.
    Diagn Interv Imaging; 2013 Jun; 94(6):629-36. PubMed ID: 23683788
    [Abstract] [Full Text] [Related]

  • 2. Relevance of diffusion-weighted imaging with background body signal suppression for staging, prognosis, morphology, treatment response, and apparent diffusion coefficient in plasma-cell neoplasms: A single-center, retrospective study.
    Yamada A, Araki Y, Tanaka Y, Otsuki S, Yamada A, Moriyama M, Katagiri S, Suguro T, Asano M, Yoshizawa S, Akahane D, Furuya N, Fujimoto H, Okabe S, Gotoh M, Suzuki K, Saito K, Gotoh A.
    PLoS One; 2021 Jun; 16(7):e0253025. PubMed ID: 34242226
    [Abstract] [Full Text] [Related]

  • 3. Pre-treatment staging of multiple myeloma patients: comparison of whole-body diffusion weighted imaging with whole-body T1-weighted contrast-enhanced imaging.
    Squillaci E, Bolacchi F, Altobelli S, Franceschini L, Bergamini A, Cantonetti M, Simonetti G.
    Acta Radiol; 2015 Jun; 56(6):733-8. PubMed ID: 24973257
    [Abstract] [Full Text] [Related]

  • 4. Apparent diffusion coefficient maps integrated in whole-body MRI examination for the evaluation of tumor response to chemotherapy in patients with multiple myeloma.
    Bonaffini PA, Ippolito D, Casiraghi A, Besostri V, Franzesi CT, Sironi S.
    Acad Radiol; 2015 Sep; 22(9):1163-71. PubMed ID: 26182979
    [Abstract] [Full Text] [Related]

  • 5. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
    Dammacco F, Rubini G, Ferrari C, Vacca A, Racanelli V.
    Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739
    [Abstract] [Full Text] [Related]

  • 6. Whole-body MRI of multiple myeloma: comparison of different MRI sequences in assessment of different growth patterns.
    Weininger M, Lauterbach B, Knop S, Pabst T, Kenn W, Hahn D, Beissert M.
    Eur J Radiol; 2009 Feb; 69(2):339-45. PubMed ID: 18096344
    [Abstract] [Full Text] [Related]

  • 7. Staging monoclonal plasma cell disease: comparison of the Durie-Salmon and the Durie-Salmon PLUS staging systems.
    Fechtner K, Hillengass J, Delorme S, Heiss C, Neben K, Goldschmidt H, Kauczor HU, Weber MA.
    Radiology; 2010 Oct; 257(1):195-204. PubMed ID: 20851941
    [Abstract] [Full Text] [Related]

  • 8. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences.
    Larbi A, Omoumi P, Pasoglou V, Michoux N, Triqueneaux P, Tombal B, Cyteval C, Lecouvet FE.
    Eur Radiol; 2019 Aug; 29(8):4503-4513. PubMed ID: 30413957
    [Abstract] [Full Text] [Related]

  • 9. Signal characteristics of focal bone marrow lesions in patients with multiple myeloma using whole body T1w-TSE, T2w-STIR and diffusion-weighted imaging with background suppression.
    Sommer G, Klarhöfer M, Lenz C, Scheffler K, Bongartz G, Winter L.
    Eur Radiol; 2011 Apr; 21(4):857-62. PubMed ID: 20853109
    [Abstract] [Full Text] [Related]

  • 10. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI.
    D'Anastasi M, Notohamiprodjo M, Schmidt GP, Dürr HR, Reiser MF, Baur-Melnyk A.
    AJR Am J Roentgenol; 2014 Oct; 203(4):854-62. PubMed ID: 25247952
    [Abstract] [Full Text] [Related]

  • 11. Whole-body MRI versus whole-body MDCT for staging of multiple myeloma.
    Baur-Melnyk A, Buhmann S, Becker C, Schoenberg SO, Lang N, Bartl R, Reiser MF.
    AJR Am J Roentgenol; 2008 Apr; 190(4):1097-104. PubMed ID: 18356461
    [Abstract] [Full Text] [Related]

  • 12. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
    Kloth JK, Hillengass J, Listl K, Kilk K, Hielscher T, Landgren O, Delorme S, Goldschmidt H, Kauczor HU, Weber MA.
    Int J Cancer; 2014 Nov 15; 135(10):2380-6. PubMed ID: 24706394
    [Abstract] [Full Text] [Related]

  • 13. Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey.
    Ghanem N, Lohrmann C, Engelhardt M, Pache G, Uhl M, Saueressig U, Kotter E, Langer M.
    Eur Radiol; 2006 May 15; 16(5):1005-14. PubMed ID: 16463030
    [Abstract] [Full Text] [Related]

  • 14. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
    Dutoit JC, Vanderkerken MA, Verstraete KL.
    Eur J Radiol; 2013 Sep 15; 82(9):1444-52. PubMed ID: 23726124
    [Abstract] [Full Text] [Related]

  • 15. Learning curves in radiological reporting of whole-body MRI in plasma cell disease: a retrospective study.
    Negroni D, Cassarà A, Trisoglio A, Soligo E, Berardo S, Carriero A, Stecco A.
    Radiol Med; 2021 Nov 15; 126(11):1451-1459. PubMed ID: 34309766
    [Abstract] [Full Text] [Related]

  • 16. [Contribution of whole-body magnetic resonance in the diagnostics of monoclonal gammopathy of undetermined significance, multiple myeloma, and the assessment of Durie-Salmon Plus staging system].
    Scudla V, Herman M, Minarík J, Pika T, Hrbek J, Bacovský J, Heinzová V.
    Vnitr Lek; 2011 Jan 15; 57(1):52-60. PubMed ID: 21351663
    [Abstract] [Full Text] [Related]

  • 17. Comparison of four MRI protocols for detection of extrahepatic colorectal cancer metastases.
    Sivesgaard K, Jöhnk ML, Larsen LP, Sørensen M, Kramer S, Løgager VB, Hansen F, Pedersen EM.
    J Magn Reson Imaging; 2017 Dec 15; 46(6):1619-1630. PubMed ID: 28301099
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
    Hur J, Yoon CS, Ryu YH, Yun MJ, Suh JS.
    Acta Radiol; 2008 May 15; 49(4):427-35. PubMed ID: 18415787
    [Abstract] [Full Text] [Related]

  • 20. Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma.
    Gutzeit A, Doert A, Froehlich JM, Eckhardt BP, Meili A, Scherr P, Schmid DT, Graf N, von Weymarn CA, Willemse EM, Binkert CA.
    Skeletal Radiol; 2010 Apr 15; 39(4):333-43. PubMed ID: 20205350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.